Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
· Glipizide 10 mg po daily
· HCTZ 25 mg daily
· Atenolol 25 mg po daily
· Hydralazine 25 mg qid
· Simvastatin 80 mg daily
· Verapamil 180 mg CD daily
Base on the highlighted scenario -
· Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
· Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
· Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
· Analyze the influence of patient factors on pharmacokinetic and pharmacodynamic processes
· Evaluate drug therapy plans for cardiovascular disorders